2025-12-21 - Analysis Report
Here's a breakdown of Tempus AI Inc. (TEM) based on the provided data:

**0) Report Summary**

*   **Performance:** TEM has underperformed the S&P 500 (VOO) significantly since its inception, with a divergence in cumulative return.
*   **Risk:** TEM is considered as Medium investment in the Market Risk Indicator, with low RSI.
*   **Moving Averages:** The stock price is below its recent moving averages, indicating a potential downtrend.
*   **News:** Recent news is mixed, with both positive (profitability outlook) and negative (stock fall, executive selling) headlines.
*   **Analyst Sentiment:** Analysts generally have a "Buy" rating with a significant price target upside, but there have been no recent rating changes.

**1) Return Analysis**

*   **Company Overview:** Tempus AI Inc. is a technology company focused on precision medicine through data analysis and artificial intelligence.
*   **TEM Cumulative Return:** 15.06%
*   **VOO Cumulative Return:** 30.11%
*   **Divergence:** -15.04% (TEM has returned 15.04% less than VOO.)
*   **Relative Divergence:** 28.8. This means the current divergence is at the 28.8th percentile of its historical range, indicating that TEM's underperformance relative to VOO is closer to its best historical relative performance than its worst, but still negative overall.

**Alpha, Beta Analysis:**

*   **CAGR (2023-2025):** 15.0%. This indicates a moderately high annualized growth rate for the period.
*   **MDD (2023-2025):** 76.7%. This is a very high Maximum Drawdown, indicating significant risk and volatility in TEM's price.
*   **Alpha (2023-2025):** -14.0%. Negative alpha suggests TEM has underperformed relative to its benchmark (market) after accounting for risk.
*   **Beta (2023-2025):** 0.3. A beta of 0.3 indicates that TEM's price is less sensitive to market movements than S&P 500, implying lower volatility than the overall market.
*   **Cap(B):** 11.5B. This signifies a market capitalization of $11.5 billion, categorizing TEM as a large-cap company.

**Analysis of Alpha, Beta Table:** While the CAGR is positive, the high MDD and negative Alpha are concerning. The low Beta suggests the stock is less volatile than the market.

**2) Recent Stock Price Fluctuations**

*   **Current Price:** \$64.46
*   **Previous Close:** \$62.21
*   **Change:** 3.62%
*   **5-day SMA:** \$65.61
*   **20-day SMA:** \$72.86
*   **60-day SMA:** \$80.13

**Analysis:** The current price is below all three moving averages (5, 20, and 60-day), suggesting a potential downtrend. The recent price increase of 3.62% might indicate a small rebound.

**3) Indicator Analysis**

*   **Market Risk Indicator (MRI):** 0.7 (Medium Investment). This suggests a moderate level of risk associated with investing in TEM.
*   **RSI:** 23.89. This is a very low RSI, indicating that TEM is oversold and might be due for a rebound.
*   **PPO:** -1.42. This suggests that the short-term moving average is below the long-term moving average, indicating a bearish trend.
*   **Hybrid Signal:** cash_0%_Buy 100% of cash. The Hybrid Signal suggests buying the stock, as the MRI indicates there are safety signs.
*   **Recent Relative Divergence Change:** -11.0 (negative trend). This indicates a short-term decline in relative performance compared to the benchmark.
*   **Expected Return (%):** Not Available (NaN). No estimation for long-term expected return.

**Analysis:** The MRI suggests a Medium Investment, but the low RSI indicates the stock is oversold and has the possibility of an uptick.

**4) Recent News & Significant Events**

*   **Stock Fell:** TEM stock fell 9% this week.
*   **First Non-GAAP Profit:** Tempus AI logged its first non-GAAP profit and has a bullish 2025 outlook.
*   **Executive Selling:** EVP Erik Phelps sold 1,302 shares.
*   **Buy, Hold, or Sell:** An article discussing whether TEM stock is a buy, hold, or sell.
*   **Growth Catalysts:** Tempus AI has plenty of growth catalysts ahead.
*   **Approaching Profitability:** Tempus AI is approaching profitability despite GAAP losses.

**Analysis:** The news paints a mixed picture. Positive news regarding profitability and growth catalysts is countered by the recent stock fall and an executive selling shares.

**4-2) Analyst Opinions**

*   **Consensus:** Buy
*   **Mean Rating:** 2.14 (Buy)
*   **Opinions:** 12
*   **Target Price (avg/high/low):** 90.17 / 105.00 / 80.00
*   **Recent Rating Changes:** No changes

**Analysis:** Analysts are generally optimistic about TEM's future, with a consensus "Buy" rating and a significant price target upside, but no recent rating changes.

**5) Comprehensive Analysis**

Tempus AI (TEM) presents a mixed investment picture. The company operates in the promising field of precision medicine and has reported its first non-GAAP profit, with potential growth catalysts. However, the stock has significantly underperformed the S&P 500, exhibiting high volatility (high MDD) and negative alpha.

Technically, the stock is in a downtrend, trading below its key moving averages and showing a negative trend in relative divergence. The low RSI suggests it may be oversold and due for a potential bounce, but the PPO points towards a bearish trend. Recent News is mixed, with some positive coverage (growth catalysts, profitability) and negative coverage (stock fall, executive selling).

Analysts maintain a "Buy" consensus with a substantial price target upside. However, there have been no recent rating changes, which would add strength to the analyst viewpoint.

**Overall Recommendation:** Considering the mixed signals, this is a high-risk, potentially high-reward investment. Investors should carefully weigh the positive catalysts (analyst optimism, growth potential) against the negative factors (underperformance, high volatility, mixed news) and the Medium MRI before making a decision.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.